Clinical trial participants help move research forward while gaining access to the latest potential treatments.
Alzheimer’s disease is a progressive form of dementia that interferes with behavior, memory, and thinking. Dementia is a broader term for memory loss and cognitive deficits that interfere with daily activities of living.
The Alzheimer’s Association estimates that 5.4 million Americans are living with Alzheimer’s disease. Most individuals with Alzheimer’s disease are diagnosed after the age of 65, but it is possible to be diagnosed earlier; this is called early-onset Alzheimer’s. According to the Alzheimer’s Association, Alzheimer’s disease makes up 50 to 80 percent of cases of dementia.